Mylan Strikes $4.5M Deal With Maryland Over EpiPen Pricing
Mylan Pharmaceuticals will pay $4.5 million to resolve allegations by the state of Maryland that Mylan acted anticompetitively when it ratcheted up costs of its portable auto-injectable EpiPen device that's used...To view the full article, register now.
Already a subscriber? Click here to view full article